XML 24 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets, Net (Tables)
 3 Months Ended
Mar. 31, 2012
Intangible Assets, Net [Abstract]  
Schedule Of Intangible Assets, Net
    March 31,     December 31,  
    2012     2011  
In-process research and development acquired in the Anchen Acquisition, net of
        accumulated amortization of $0 and $0		   $ 124,700       126,700  
Developed products acquired in the Anchen Acquisition, net of accumulated amortization
        of $7,274 and $1,650		     77,926       83,550  
QOL Medical, LLC Asset Purchase Agreement, net of accumulated amortization of
        $13,680 and $12,540		     41,041       42,181  
Teva Pharmaceuticals, Inc. Asset Purchase Agreement, net of accumulated amortization
        of $2,027 and $1,255		     15,973       16,745  
Glenmark Generics Limited and Glenmark Generics, Inc. USA Licensing Agreement, net
        of accumulated amortization of $0 and $0		     15,000       15,000  
Synthon Pharmaceuticals, Inc. Asset Purchase Agreement, net of accumulated
        amortization of $0 and $0		     9,600       9,600  
Covenant not-to-compete acquired in the Anchen Acquisition, net of accumulated
        amortization of $1,100 and $358		     7,800       8,542  
Teva Pharmaceuticals, Inc. License and Distribution Agreement, net of accumulated
        amortization of $0 and $0		     6,000       6,000  
In-process research and development acquired in the Edict Acquisition, net of
        accumulated amortization of $0		     1,100       -  
Covenant not-to-compete acquired in the Edict Acquisition, net of accumulated
        amortization of $0		     750       -  
Genpharm, Inc. Distribution Agreement, net of accumulated amortization of $9,929
        and $9,748		     904       1,085  
Trademark licensed from Bristol-Myers Squibb Company, net of accumulated
        amortization of $9,528 and $9,148		     472       852  
SVC Pharma LP License and Distribution Agreement, net of accumulated amortization
        of $3,210 and $3,034		     474       650  
MDRNA, Inc. Asset Purchase Agreement, net of accumulated amortization of $1,926 and $1,750     174       350  
Other intangible assets, net of accumulated amortization of $7,220 and $7,209     403       414  
    $ 302,317     $ 311,669  
Schedule Of Estimated Amortization Expense
      Estimated  
      Amortization  
      Expense  
  2012     $ 29,412  
  2013       33,517  
  2014       49,117  
  2015       44,820  
  2016       40,378  
  2017 and thereafter       105,073  
        $ 302,317